Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

$19.99

Common-Size Balance Sheet: Assets

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Bristol-Myers Squibb Co. for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Bristol-Myers Squibb Co., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Cash and cash equivalents
Marketable debt securities
Net trade receivables
Alliance, Royalties, VAT and other
Receivables
Inventories
Income taxes
Research and development
Contract assets
Equity investments
Restricted cash
Assets held-for-sale
Other
Other current assets
Current assets
Property, plant and equipment
Goodwill
Other intangible assets
Deferred income taxes
Marketable debt securities
Equity investments
Inventories
Operating lease right-of-use assets
Pension and postretirement
Research and development
Restricted cash
Other
Other non-current assets
Non-current assets
Total assets

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Bristol-Myers Squibb Co. current assets as a percentage of total assets increased from 2019 to 2020 and from 2020 to 2021.
Property, plant and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Bristol-Myers Squibb Co. property, plant and equipment as a percentage of total assets increased from 2019 to 2020 and from 2020 to 2021.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Bristol-Myers Squibb Co. non-current assets as a percentage of total assets decreased from 2019 to 2020 and from 2020 to 2021.